|
BBO-10203 Clinical Trials
3 actively recruiting trials across 3 locations
▲ +1 trial since June 2026
Pipeline
Phase 1: 3
Top Sponsors
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)3
Indications
- Lung Cancer3
- Cancer3
- Advanced Lung Carcinoma2
- KRAS G12C2
- Metastatic Lung Cancer2
Birmingham, Alabama1 trial
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
O'Neal Comprehensive Cancer Center at UAB
Phase 1
Duarte, California1 trial
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
City of Hope Comprehensive Cancer Center
Phase 1
Los Angeles, California1 trial
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
The Angeles Clinic and Research Institute - West Los Angeles Office
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.